Nano-X Imaging Ltd, a digital-imaging device maker for medical purposes, has filed Amendment No2 to Form F-1 Registration Statement on August 20, 2020 with the U.S Securities and Exchange Commission to raise the proposed IPO size to 8.8 million shares.
The company now plans to raise $150 million by offering 8.8 million shares at the price range of $16 to $18. Previously the company proposed to offer 5.9 million shares at same price range.
The company designed Nanox System to enable medical screening to improve accessibility and affordability of early-detection services worldwide. It also developed prototype in both hardware and software.
The Neve Ilan, Israel-based company was founded in 2018. It plans to list on the Nasdaq Global Market under the symbol “NNOX.” Cantor Fitzgerald, Oppenheimer & Co., Berenberg and CIBC are underwriters of the IPO.
The company engages Skadden, Arps, Slate, Meagher & Flom LLP as US Securities Counsel, and PricewaterhouseCoopers International Limited as Independent Auditor.
It is expected to close the IPO during the week of August 17, 2020.
#ipo #nasdaq #PwC #Nanox #heathcare #imagingdevice #technology
Hexcellence Consulting has experienced IPO consulting team focus on listing in US Stock Market,
namely NYSE, Nasdaq and OTC Markets.
Should you interested to list your company in US Stock Market,
please contact us at [email protected].
